PMID- 35008044 OWN - NLM STAT- MEDLINE DCOM- 20220308 LR - 20220308 IS - 1476-1645 (Electronic) IS - 0002-9637 (Print) IS - 0002-9637 (Linking) VI - 106 IP - 2 DP - 2022 Jan 10 TI - Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. PG - 525-531 LID - tpmd201436 [pii] LID - 10.4269/ajtmh.20-1436 [doi] AB - Intensive care unit-acquired infection (ICU-AI) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage are a major concern worldwide. Our objective was to investigate the impact of ESBL-PE carriage on ICU-AI. Our study was prospective, observational, and noninterventional. It was conducted over a 5-year period (Jan 2013-Dec 2017) in the medical-surgical intensive care unit of the Cayenne General Hospital (French Amazonia). During the study period, 1,340 patients were included, 271 (20.2%) developed ICU-AI, and 16.2% of these were caused by ESBL-PE. The main sites of ICU-AI were ventilator-associated pneumonia (35.8%) and primary bloodstream infection (29.8%). The main responsible microorganisms were Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae (ESBL-P in 35.8% of isolates), and Enterobacter cloacae (ESBL-P in 29.8% of isolates). Prior ESBL-PE carriage was diagnosed in 27.6% of patients with ICU-AI. In multivariable analysis, the sole factor associated with ESBL-PE as the responsible organism of ICU-AI was ESBL-PE carriage before ICU-AI (P < 0.001; odds ratio: 7.9 95% CI: 3.4-18.9). ESBL-PE carriers (74 patients) developed ICU-AI which was caused by ESBL-PE in 32 cases (43.2%). This proportion of patients carrying ESBL-PE who developed ICU-AI to the same microorganism was 51.2% in ESBL-P K. pneumoniae, 5.6% in ESBL-P Escherichia coli, and 40% in ESBL-P Enterobacter spp. NPV of ESBL-PE carriage to predict ICU-AI caused by ESBL-PE was above 94% and PPV was above 43%. Carriage of ESBL-P K pneumoniae and Enterobacter spp. is a strong predictor of ICU-AI caused by these two microorganisms. FAU - Kallel, Hatem AU - Kallel H AD - Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana. AD - Tropical Biome and Immunophysiopathology (TBIP), Universite de Guyane, Cayenne, French Guiana. AD - Univ. de Lille, CNRS, Inserm, Institut Pasteur de Lille, Lille, France. FAU - Houcke, Stephanie AU - Houcke S AD - Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana. FAU - Resiere, Dabor AU - Resiere D AD - Intensive Care Unit, Martinique University Hospital, Fort de France, Martinique. FAU - Court, Thibault AU - Court T AD - Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana. FAU - Roncin, Cesar AU - Roncin C AD - Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana. FAU - Raad, Mathieu AU - Raad M AD - Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana. FAU - Nkontcho, Flaubert AU - Nkontcho F AD - Pharmacy Department, Cayenne General Hospital, Cayenne, French Guiana. FAU - Demar, Magalie AU - Demar M AD - Tropical Biome and Immunophysiopathology (TBIP), Universite de Guyane, Cayenne, French Guiana. AD - Univ. de Lille, CNRS, Inserm, Institut Pasteur de Lille, Lille, France. AD - Laboratory of Microbiology, Cayenne General Hospital, Cayenne, French Guiana. FAU - Pujo, Jean AU - Pujo J AD - Emergency Department, Cayenne General Hospital, Cayenne, French Guiana. FAU - Hommel, Didier AU - Hommel D AD - Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana. FAU - Djossou, Felix AU - Djossou F AD - Tropical Biome and Immunophysiopathology (TBIP), Universite de Guyane, Cayenne, French Guiana. AD - Univ. de Lille, CNRS, Inserm, Institut Pasteur de Lille, Lille, France. AD - Tropical and Infectious Diseases Department, Cayenne General Hospital, Cayenne, French Guiana. LA - eng PT - Journal Article PT - Observational Study DEP - 20220110 PL - United States TA - Am J Trop Med Hyg JT - The American journal of tropical medicine and hygiene JID - 0370507 RN - EC 3.5.2.6 (beta-Lactamases) SB - IM MH - Adult MH - Carrier State/*diagnosis MH - Cross Infection/*microbiology MH - Enterobacter cloacae/enzymology MH - Enterobacteriaceae/classification/*enzymology MH - Enterobacteriaceae Infections/classification/*microbiology MH - Female MH - French Guiana/epidemiology MH - Humans MH - *Intensive Care Units MH - Klebsiella pneumoniae/enzymology MH - Male MH - Middle Aged MH - Prospective Studies MH - Pseudomonas aeruginosa/enzymology MH - Staphylococcus aureus/enzymology MH - *beta-Lactamases PMC - PMC8832904 EDAT- 2022/01/11 06:00 MHDA- 2022/03/09 06:00 PMCR- 2022/01/10 CRDT- 2022/01/10 20:35 PHST- 2020/11/13 00:00 [received] PHST- 2021/03/28 00:00 [accepted] PHST- 2022/01/11 06:00 [pubmed] PHST- 2022/03/09 06:00 [medline] PHST- 2022/01/10 20:35 [entrez] PHST- 2022/01/10 00:00 [pmc-release] AID - tpmd201436 [pii] AID - 10.4269/ajtmh.20-1436 [doi] PST - epublish SO - Am J Trop Med Hyg. 2022 Jan 10;106(2):525-531. doi: 10.4269/ajtmh.20-1436.